Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ContextVision ABOSL:CONTX +0.30%77 Return-on-Tangible-Asset is 2.69% as of Mar. 2026, which is 69% below its 10-year median of 8.80. GuruFocus rates OSL:CONTX with a GF Score™ of 77/100 and a GF Value™ of kr5.12 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 682 Healthcare Providers & Services companies, ContextVision AB ranks better than 57.04% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. ContextVision AB's annualizedNet Income for the quarter that ended in Mar. 2026 was kr3.5 Mil. ContextVision AB's average total tangible assets for the quarter that ended in Mar. 2026 was kr131.1 Mil. Therefore, ContextVision AB's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 2.69%.
The historical rank and industry rank for ContextVision AB's Return-on-Tangible-Asset or its related term are showing as below:
OSL:CONTX'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -8.11 Med: 8.8 Max: 35.4
Current: 3.95
During the past 13 years, ContextVision AB's highest Return-on-Tangible-Asset was 35.40%. The lowest was -8.11%. And the median was 8.80%.
OSL:CONTX's Return-on-Tangible-Asset is ranked better than 57.04% of 682
companies
in the Healthcare Providers & Services industry
Industry Median: 2.465
vs OSL:CONTX: 3.95
ContextVision AB (OSL:CONTX) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
ContextVision AB Return-on-Tangible-Asset Related Terms
ContextVision AB Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for ContextVision AB's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSL:CONTX vs VEEV, BTSG, TEM: Return-on-Tangible-Asset Comparison
For the Health Information Services subindustry, ContextVision AB's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ContextVision AB Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, ContextVision AB's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where ContextVision AB's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 2.69% mean?
ContextVision AB (OSL:CONTX) has a Return-on-Tangible-Asset of 2.69% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on ContextVision AB and its competitors. This is 69% below median its historical median of 8.80. According to the industry distribution chart, ContextVision AB ranks #293 out of 682 companies in the Healthcare Providers & Services industry, placing it in the top 43%.
Is ContextVision AB's Return-on-Tangible-Asset too high?
ContextVision AB's current Return-on-Tangible-Asset of 2.69% is 69% below median its 10-year median of 8.80. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.47. ContextVision AB's value of 2.69% is 9.1% above this industry median. Based on the distribution chart, ContextVision AB ranks #293 out of 682 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, ContextVision AB has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ContextVision AB's Return-on-Tangible-Asset compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, ContextVision AB ranks #293 out of 682 companies for Return-on-Tangible-Asset. This puts ContextVision AB in the upper half of its industry. The industry median Return-on-Tangible-Asset is 2.47. ContextVision AB's value of 2.69% is 9.1% above this benchmark. While the company's 10-year median is 8.80 vs. the industry median of 2.47, ContextVision AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.47, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ContextVision AB's current Return-on-Tangible-Asset of 2.69% is 9.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on ContextVision AB and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ContextVision AB's current Return-on-Tangible-Asset is 2.69%, which is 69% below median its own 10-year median of 8.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ContextVision AB stock overvalued right now?
Based on GuruFocus' analysis, ContextVision AB (OSL:CONTX) is currently considered Significantly Undervalued. The stock's GF Value™ is kr5.12, compared to a current price of kr3.35 — trading 34.6% below its estimated fair value. The current Return-on-Tangible-Asset is 2.69%, which is 69% below median its 10-year median of 8.80 and 9.1% above the Healthcare Providers & Services industry median of 2.47. ContextVision AB's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For ContextVision AB (OSL:CONTX), the current Return-on-Tangible-Asset is 2.69% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ContextVision AB (OSL:CONTX) Overvalued in 2026?
Based on GuruFocus' analysis, ContextVision AB stock appears to be undervalued.
The current stock price of kr3.35 is trading 34.6% below its estimated GF Value™ of kr5.12.
GuruFocus considers ContextVision AB to be Significantly Undervalued.
Key valuation signals for OSL:CONTX:
Return-on-Tangible-Asset: 2.69% (69% below median its 10-year median of 8.80)
GF Value™: kr5.12 vs. price of kr3.35 (34.6% below fair value)
Industry Position: 9.1% above the Healthcare Providers & Services median (#293 of 682)
No single metric tells the full story. See the OSL:CONTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ContextVision AB is a medical technology company. It develops and sells image enhancement software for medical diagnosis and artificial intelligence. Its product portfolio includes image enhancement software for 2D/3D/4D (dimensional) ultrasound, magnetic resonance imaging (MRI), X-Ray, radiography, and mammography. Its geographical segments are Asia, Europe, and America.
77GF Score
Get the complete analysis for OSL:CONTX
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:CONTX has been successfully added to your 
